Data Foundry

Drug recalls 2021

Tinactin — Class II drug recall D-0242-2022

Terminated recall by Bayer Healthcare Pharmaceuticals Inc., reported 2021-11-24, distributed nationwide. cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene

Recall numberD-0242-2022
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmBayer Healthcare Pharmaceuticals Inc., Whippany, NJ, United States
Recall initiated2021-10-01
Classified2021-11-18
Reported by FDA2021-11-24
Terminated2023-06-26
DistributedNationwide (US)
Countries outside the USCA, MX
Quantity738,432 cans
Reason classeschemical contamination, cgmp
UPC / GTIN / UDI-DI00311017410004
NDC11017-0410-00, 11523-4162, 11523-4162-01
Lot numbersTN004BW, TN00678, TN00679
Expiration dates2022-07-31, 2022-08-31, 2022-09-30

Product

Tinactin (Tolnaftate 1%) DEODORANT POWDER SPRAY NET WT 133g (4.6 OZ) can, labeled as (a) UPC 3 11017-410-00 4, NDC 11523-4162-1, Product of Finland 86568411; (b) UPC 3 11017 41000 4, NDC 11523-4162-1, Product of Finland 20006105; Dist by: Bayer Healthcare LLC, Whippany, NJ 07981

Reason for recall

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0242-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.